Drug Approval | October 06, 2021
WHO decision on Covaxin approval next week
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
It is a recombinant nanoparticle protein-based vaccine
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
Filing for WHO Emergency Use Authorisation this month
Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Subscribe To Our Newsletter & Stay Updated
